Management of the patient for transcatheter aortic valve implantation in the perioperative period

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 1, 2012, Pages 25-40

  Huffmyer, Julie ^a   Tashjian, Jessica ^a   Raphael, Jacob ^a   Jaeger, J Michael ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANESTHETIC AGENT; CLEVIDIPINE; HEPARIN; INOTROPIC AGENT; LOCAL ANESTHETIC AGENT; MILRINONE; NARCOTIC ANALGESIC AGENT; NICARDIPINE; NITROPRUSSIDE SODIUM; PARACETAMOL; PROTAMINE SULFATE; TRAMADOL; WARFARIN;

ACUTE KIDNEY FAILURE; ANESTHESIA INDUCTION; ANTICOAGULANT THERAPY; AORTA DISSECTION; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL EMBOLISM; ATRIOVENTRICULAR BLOCK; BALLOON CATHETER; BLEEDING; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; BRADYCARDIA; CARDIOPULMONARY BYPASS; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); COMORBIDITY; CORONARY ARTERY OBSTRUCTION; CYANIDE POISONING; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG METABOLISM; ECHOCARDIOGRAPHY; EPIDURAL ANESTHESIA; FEMORAL ARTERY; FLUOROSCOPY; GENERAL ANESTHESIA; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PRELOAD; HUMAN; HYPERGLYCEMIA; HYPOTENSION; INTRAOPERATIVE PERIOD; LOADING DRUG DOSE; MITRAL VALVE REGURGITATION; MORBIDITY; NEUROLOGICAL COMPLICATION; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PATIENT MONITORING; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PNEUMOTHORAX; POSTOPERATIVE ANALGESIA; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PREOPERATIVE EVALUATION; PULMONARY HYPERTENSION; QUALITY OF LIFE; RESUSCITATION; SEDATION; SIDE EFFECT; STENT; STROKE; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; SYMPTOM; THORACOTOMY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VALVULOPLASTY; VASODILATATION; VENOUS THROMBOEMBOLISM;

ACUTE KIDNEY INJURY; ANESTHESIA; ANIMALS; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BLOOD VESSELS; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART CATHETERIZATION; HEART CONDUCTION SYSTEM; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; INTRAOPERATIVE CARE; PAIN, POSTOPERATIVE; PERIOPERATIVE CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 84858688940     PISSN: 10892532     EISSN: 19405596     Source Type: Journal    
DOI: 10.1177/1089253211434966     Document Type: Article

References (94)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol. 1997 ; 29: 630-634 (Pubitemid 27116107)
2. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997 ; 95: 2262-2270 (Pubitemid 27191003)
3. Bonow RO, Carabello B, de Leon AC. Guidelines for the management of patients with valvular heart disease: executive summary. Circulation. 1998 ; 98: 1949-1984
4. Ross J, Braumwald E. Aortic stenosis. Circulation. 1968 ; 38 (suppl 5). 61-67
5. O'Brien KD, Zhao XQ, Shavelle DM, et al. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function. J Investig Med. 2004 ; 52: 185-191 (Pubitemid 38856421)
6. Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 ; 359: 1343-1356
7. Varadarajan P, Kapoor N, Ramesh C, et al. Ann Thorac Surg. 2006 ; 82: 2111-2115
8. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2008 ; 52: e1 - e142
9. Bonow RO, Carabello BA, Chatterjee K, et al. Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006 ; 48: e1 - e148
10. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007 ; 28: 230-268 (Pubitemid 46276943)
11. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 ; 106: 3006-3008 (Pubitemid 35440280)
12. European System for Cardiac Operative Risk Evaluation. www.euroscore.org. Accessed December 28, 2011.
13. Online STS risk calculator. http://209.220.160.181/STSWebRiskCalc261/. Accessed December 28, 2011.
14. Gummert JF, Funkat A, Osswald B, et al. EuroSCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol. 2009 ; 98: 363-369
15. Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J. 2009 ; 30: 74-80
16. Wendt D, Osswald BR, Kayser K, et al. Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement. Ann Thorac Surg. 2009 ; 88: 468-475
17. Dewey TM, Brown D, Ryan WH, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008 ; 135: 180-187
18. ClinicalTrials.gov. THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial. http://clinicaltrials.gov/ct2/show/NCT00530894. Accessed December 28, 2011.
19. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 ; 363: 1597-1607
20. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 ; 364: 2187-2198
21. Leon MB, Kodali S, Williams M, et al. Transcatheter aortic valve replacement in patients with critical aortic stenosis: rationale, device descriptions, early clinical experiences, and perspectives. Semin Thorac Cardiovasc Surg. 2006 ; 18: 165-174 (Pubitemid 44835260)
22. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011 ; 32: 191-197
23. Ewe SH, Delgado V, Ng AC, et al. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg. 2011 ; 92: 1244-1251
24. Johansson M, Nozohoor S, Kimblad PO, et al. Transapical versus transfemoral aortic valve implantation: a comparison of survival and safety. Ann Thorac Surg. 2011 ; 91: 57-63
25. Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and transfemoral aortic valve implantation: talking about two different patient populations. J Thorac Cardiovasc Surg. 2009 ; 138: 1073-1080
26. Wilson A, Toggweiler S, Webb JG. Transfemoral aortic valve replacement with the SAPIEN XT valve: step-by-step. Semin Thorac Cardiovasc Surg. 2011 ; 23: 51-54
27. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009 ; 53: 1829-1836
28. Mukherjee C, Walther T, Borger MA, et al. Awake transapical aortic valve implantation using thoracic epidural anesthesia. Ann Thorac Surg. 2009 ; 88: 992-994
29. Vavuranakis M, Voudris V, Vrachatis DA, et al. Transcatheter aortic valve implantation, patient selection process and procedures: two centres' experience of the intervention without general anesthesia. Hellenic J Cardiol. 2010 ; 51: 492-500
30. Bagur R, Rodes-Cabau J, Doyle D, et al. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging. 2011 ; 4: 115-124
31. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation. 1978 ; 58: 255-264 (Pubitemid 8395930)
32. Krayenbuehl HP, Hess OM, Monrad ES, et al. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. 1989 ; 79: 744-755 (Pubitemid 19100533)
33. Christakis GT, Joyner CD, Morgan CD, et al. Left ventricular mass regression early after aortic valve replacement. Ann Thorac Surg. 1996 ; 62: 1084-1089 (Pubitemid 26340327)
34. Hess OM, Ritter M, Schneider J, et al. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation. 1984 ; 69: 855-865 (Pubitemid 14137280)
35. Villari B, Vassalli G, Monrad ES, et al. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation. 1995 ; 91: 2353-2358
36. Villari B, Sossalla S, Ciampi Q, et al. Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation. Circulation. 2009 ; 120: 2386-2392
37. Blitz LR, Gorman M, Herrmann HC. Results of aortic valve replacement for aortic stenosis with relatively low transvalvular pressure gradients. Am J Cardiol. 1998 ; 81: 358-362 (Pubitemid 28099318)
38. Tsai S-C, Adamik R, Manganiello VC, Moss J. Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava. Biochem Pharmacol. 1989 ; 38: 61-65 (Pubitemid 19029154)
39. Cohen JN, Franciosa JA, Francis GS, et al. Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. N Engl J Med. 1982 ; 306: 1129-1135 (Pubitemid 12161335)
40. Friederich JA, Butterworth JF. Sodium nitroprusside: twenty years and counting. Anesth Analg. 1995 ; 81: 152-162
41. Dupuis J, LaLonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation, and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990 ; 16: 923-931 (Pubitemid 20353414)
42. Levy JH, Mancao MY, Gitter R, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anesth Analg. 2007 ; 105: 918-925 (Pubitemid 47479301)
43. Jaski BE, Fifer MA, Wruight RF, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. J Clin Invest. 1985 ; 75: 643-649
44. Pattison A, Astley N, Eason CT, Bonner FW. A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood. Thromb Res. 1990 ; 57: 909-918 (Pubitemid 20149005)
45. Kikura M, Kazama T, Ikeda T, Sato S. Disaggregatory effects of prostaglandin E1, amrinone, and milrinone on platelet aggregation in human whole blood. Platelets. 2000 ; 11: 446-458 (Pubitemid 32147031)
46. Kikura M, Lee MK, Safon RA, et al. The effects of milrinone on platelets in patients undergoing cardiac surgery. Anesth Analg. 1995 ; 81: 44-48
47. Guinot P-G, Depoix J-P, Etchegoyen L, et al. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth. 2010 ; 24: 752-761
48. Mannin SC, Brennan TJ. Thoracic epidural analgesia and acute pain management. Anesth Analg. 2011 ; 115: 181-188
49. Davies RG, Myles PS, Graham JM, et al. epidural blockade for thoracotomy: systemic review and metaanalysis of randomized trials. Br J Anaesth. 2006 ; 96: 418-426
50. O'Connor CJ. Thoracic epidural analgesia: physiologic effects and clinical applications. J Cardiothoracic Vasc Anesth. 1993 ; 7: 595-609 (Pubitemid 23310749)
51. Casati A, Alessandrini P, Nuzzi M, et al. A prospective, randomized, blinded comparison between continuous thoracic paravertebral and epidural infusion of 0.2% ropivacaine after lung resection surgery. Eur J Anaesth. 2006 ; 23: 999-1004 (Pubitemid 44622926)
52. Kotze A, Scally A, Howell S. Efficacy and safety of different techniques of paravertebral block for analgesia after thoracotomy: a systematic review and metaregression. Br J Anaesth. 2009 ; 103: 626-636
53. Pinteric TS, Potocnik I, Hadzic A, et al. Comparison of continuous thoracic epidural with paravertebral block on perioperative analgesia and hemodynamic stability in patients having open lung surgery. Reg Anesth Pain Med. 2011 ; 36: 256-260
54. Hara K, Sakura S, Nomura T, Saito Y. Ultrasound guided paravertebral block in breast surgery. Anaesthesia. 2009 ; 64: 223-224
55. Boezaart AP, Lucas SD, Elliott CE. Paravertebral block: cervical,thoracic, lumbar, and sacral. Curr Opin Anaesthesiol. 2009 ; 22: 637-643
56. Chin KJ, Karmaker MK, Peng P. Ultrasonography of the adult thoracic and lumbar spine for central neuraxial blockade. Anesth Analg. 2011 ; 114: 1459-1485
57. Cribier A, Eltchaninoff H, Tron C, et al. Percutaneous implantation of aortic valve prosthesis in patients with calcific aortic stenosis. J Interv Cardiol. 2006 ; 19: S87 - S96
58. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and third-generation self-expanding CoreValve prosthesis. J Am Coll Cardiol. 2007 ; 50: 69-76 (Pubitemid 46970878)
59. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J. 2010 ; 31: 1398-1403
60. Grube E, Buellesfeld , Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving System. Circ Cardiovasc Interv. 2008 ; 1: 167-175
61. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 ; 363: 1597-1607
62. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one-year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011 ; 12: 762-767
63. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010 ; 122: 62-69
64. Buellesfeld L, Gerckens U, Schuler G, et al. Two-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011 ; 57: 1650-1657
65. Figulla L, Neumann A, Figulla HR, et al. Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy: a systematic review of current literature. Clin Res Cardiol. 2011 ; 100: 265-276
66. Gotzmann M, Bojara W, Lindstaedt M, et al. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol. 2011 ; 107: 1687-1692
67. Al Ali AM, Altwegg L, Horlick EM, et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv. 2008 ; 72: 573-578
68. Sherif MA, Abdel-Wahab M, Stocker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010 ; 56: 1623-1629
69. Rajani R, Kakrad M, Khawaja MZ, et al. Paravalvular regurgitation one year after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010 ; 75: 868-872
70. Stabile E, Sorropago G, Cota L, et al. Management of percutaneous aortic valve malposition with a transapical "valve-in-valve" technique. Ann Thorac Surg. 2010 ; 89: e19 - e21
71. Tay EL, Gurvitch R, Wijeysinghe N, et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv. 2011 ; 4: 228-234
72. Astarci P, Desiron Q, Glineur D, El Khoury G. Transapical explantation of an embolized transcatheter valve. Interact Cardiovasc Thorac Surg. 2011 ; 13: 1-2
73. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation. Circulation. 2010 ; 121: 870-878
74. Rodes-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011 ; 57: 18-28
75. Arnold M, Schulz-Heise S, Achenbach S, et al. Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv. 2002 ; 3: 1126-1132
76. Erkapic D, Kim WK, Weber M, et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace. 2010 ; 12: 1188-1190
77. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J. 2009 ; 157: 860-866
78. Roten L, Wenaweser P, Delacreatz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010 ; 106: 1473-1480
79. Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011 ; 107: 747-754
80. Tzikas A, van Dalen BM, Van Mieghem NM, et al. Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol. 2011 ; 107: 285-289
81. Matthews IG, Fazal IA, Bates MGD, Turley AJ. In patients undergoing aortic valve replacement, what factors predict the requirements for permanent pacemaker implantation?. Interact Cardiovasc Thorac Surg. 2011 ; 12: 475-479
82. Edwards F, Peterson E, Coombs L, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001 ; 37: 885-892 (Pubitemid 32202459)
83. Wijeysundera DN, Karkouti K, Beattie WS, et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology. 2006 ; 104: 65-72
84. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004 ; 15: 1597-1605 (Pubitemid 38679685)
85. Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998 ; 104: 343-348 (Pubitemid 28211024)
86. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE criteria. Ann Thorac Surg. 2006 ; 81: 542-546 (Pubitemid 43120552)
87. Tuttle KR, Worrall NK, Dahlstrom LR, et al. Predictors of ARF after cardiac surgical procedures. Am J Kidney Dis. 2003 ; 41: 76-83 (Pubitemid 36043353)
88. Nuis R-JM, Van Mieghem NM, Tzikas A, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010 ; 77: 881-889
89. Strauch JT, Scherener MP, Haldenwang PL, et al. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. Ann Thorac Surg. 2010 ; 89: 465-470
90. Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010 ; 31: 865-874
91. Elhmidi Y, Bleiziffer S, Piazza N, et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J. 2011 ; 161: 735-739
92. Rodes-Cabau J, Gutierrez M, Bagur R, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011 ; 57: 1988-1999
93. Gerber RT, Osborn M, Mikhail GW. Delayed mortality from aortic dissection post transcatheter aortic valve implantation (TAVI): the tip of the iceberg. Catheter Cardiovasc Interv. 2010 ; 76: 202-204
94. Hayashida K, Lefevre T, Chevalier B, et al. Transfemoral aortic valve implantation: new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011 ; 4: 851-858